IL6 and atherosclerosis: Experimental results showed that the IL-6 level in the galangin-treated group decreased from 9.64 to 5.42 mg/L, and TNF-α decreased from 6.63 to 3.57 mg/L in the atherosclerosis model (Qi et al., 2025).